Key Takeaways
- Moa Technology, an Oxford, UK-based agricultural biotechnology company, raised $29.7 million (£22.2 million) in Series C funding co-led by Oxford Science Enterprises and Supernova Invest.
- New investors Agri Investment Fund (AIF), GrainInnovate, Infinity Investment Partners, and Magdalen College Oxford joined existing backers Oxford Science Enterprises, Lansdowne Partners, Parkwalk, and Oxford University Innovation.
- Moa's platforms have screened more than 900,000 compounds and identified over 80 novel mode of action areas capable of breaking weed resistance to existing herbicides.
- The company has built R&D partnerships with Nufarm, Gowan, Certis Belchim, and Corteva Agriscience over the past 24 months.
- The funding will push Moa's three most advanced herbicide programs toward commercialization and expand its Moa Amplifiers line, a category of products discovered in 2025.
Moa Technology Closes $29.7 Million Series C Round
Moa Technology, an Oxford, England-based agricultural biotechnology company, announced a $29.7 million (approximately £22.2 million) Series C financing round on July 23, 2026. The round was co-led by Oxford Science Enterprises (OSE) and Supernova Invest, two firms that have backed the company since its early days as a spinout from the University of Oxford's Plant Sciences Department in 2017.
Moa focuses on discovering herbicides with new modes of action, aiming to give farmers tools that can overcome the growing problem of weed resistance to existing chemistries. The investor group behind this round reflects growing interest in crop protection biotech from both financial and strategic backers.
New and Existing Investors Back the Round
Joining Supernova as new investors are Agri Investment Fund (AIF), GrainInnovate (a fund investing on behalf of Australia's Grain Research Development Corporation and managed by Artesian), Infinity Investment Partners, and Magdalen College Oxford. Existing investors OSE, Lansdowne Partners, Parkwalk, and Oxford University Innovation also took part in the round. Moa said the new equity will be supplemented by upfront and milestone payments from its current and future industry partners.
Executives on the Investment
“This marks a major milestone for Moa Technology – a validation of the outstanding progress we have made not just in the laboratory, but also in striking commercial deals with leading industry partners around the world,” said Dr. Virginia Corless, CEO of Moa Technology. “We are particularly pleased that, through AIF in Europe and GrainInnovate in Australia, the farming sector itself is closely connected to the next phase of Moa's development, helping accelerate delivery of our solutions to the fields where they are so urgently needed.”
“The success of the platform's discoveries since in the lab and field trials has confirmed Moa is on track to provide the new solutions farmers need to sustain agricultural productivity, and we're delighted to be supporting the company again in this fundraising round,” said Martin Fiennes of Oxford Science Enterprises.
Moa Technology's Path to Commercialization
Moa's proprietary platforms have screened more than 900,000 compounds and identified over 80 novel mode of action areas that work in different ways to control weeds and break resistance. Several of its most advanced programs are now in their third year of international field trials. In the past two years, Moa has formed research collaborations with crop protection companies Nufarm, Gowan, Certis Belchim, and Corteva Agriscience, and expects to sign further commercial partnerships. The Series C proceeds will fund the three most advanced programs through to commercialization, build out Moa's earlier-stage pipeline, and expand Moa Amplifiers, a 2025 discovery that reduces the amount of herbicide needed rather than acting as a standalone weed killer.
